China: MSF challenges Gilead’s patent application for hepatitis C treatment - Hallo friendsTHE LEK NEWS, In the article you read this time with the title China: MSF challenges Gilead’s patent application for hepatitis C treatment, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article culture, Article economy, Article health, Article healthy tips, Article news, Article politics, Article sports, We write this you can understand. Alright, good read.

Title : China: MSF challenges Gilead’s patent application for hepatitis C treatment
link : China: MSF challenges Gilead’s patent application for hepatitis C treatment

China: MSF challenges Gilead’s patent application for hepatitis C treatment

In case you missed it

China: MSF challenges Gilead’s patent application for hepatitis C treatment

Médecins Sans Frontières (MSF) has filed a legal patent challenge in China against US pharmaceutical corporation Gilead’s patent application for the combination of two crucial oral hepatitis C medicines, sofosbuvir and velpatasvir. This combination is the first direct-acting antiviral (DAA) treatment to be registered for use against all genotypes of the disease. Rejection of patents for this combination would pave the way towards the availability of affordable generic versions of this treatment that millions of people need in China and around the world....

Read more: http://ift.tt/2ozG5NO

Thus Article China: MSF challenges Gilead’s patent application for hepatitis C treatment

That's an article China: MSF challenges Gilead’s patent application for hepatitis C treatment This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article China: MSF challenges Gilead’s patent application for hepatitis C treatment with the link address https://theleknews.blogspot.com/2017/12/china-msf-challenges-gileads-patent.html

Tweet

Subscribe to receive free email updates: